A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Subscribe to Continue Reading
Uh oh–you've read all five of your free articles for this month.
Insider Online Only
$19.95/yr US PRICE
The Unintended Consequence of Congress’s Ban on Designer Babies
The testing of new therapies to prevent a debilitating mitochondrial genetic disease in babies has hit a dead end.
How the Mathematics of Algebraic Topology Is Revolutionizing Brain Science
Nobody understands the brain’s wiring diagram, but the tools of algebraic topology are beginning to tease it apart.
Manufacturing Dopamine in the Brain with Gene Therapy
A novel solution for Parkinson’s patients who find their treatments wearing off.